BRONCOCHEM MAXIMUM COUGH 20 mg/10mL
DEXTROMETHORPHAN HBr-GYAIFENESIN · SYRUP · LABORATORIO MAGNACHEM INTERNATIONAL SRL
BRONCOCHEM MAXIMUM COUGH is a syrup containing dextromethorphan hbr-gyaifenesin at 20 mg/10mL, taken oral. Manufactured by LABORATORIO MAGNACHEM INTERNATIONAL SRL.
Key Facts
- Brand Name
- BRONCOCHEM MAXIMUM COUGH
- Generic Name
- DEXTROMETHORPHAN HBr-GYAIFENESIN
- NDC Code (Product)
65131-100- Manufacturer
- LABORATORIO MAGNACHEM INTERNATIONAL SRL
- Strength
- 20 mg/10mL
- Dosage Form
- SYRUP
- Route
- ORAL
- Marketing Status
- Application #
- M
- Drug Class
- Expectorant [EPC]
- Marketing Start
- 04/21/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is BRONCOCHEM MAXIMUM COUGH used for?
BRONCOCHEM MAXIMUM COUGH contains DEXTROMETHORPHAN HBr-GYAIFENESIN. It is a syrup taken oral. Consult your doctor for specific uses.
Is BRONCOCHEM MAXIMUM COUGH a controlled substance?
BRONCOCHEM MAXIMUM COUGH is not classified as a controlled substance by the DEA.
What is the generic name for BRONCOCHEM MAXIMUM COUGH?
The generic name for BRONCOCHEM MAXIMUM COUGH is DEXTROMETHORPHAN HBr-GYAIFENESIN. There are no other listed brand versions of DEXTROMETHORPHAN HBr-GYAIFENESIN.
What is the NDC code for BRONCOCHEM MAXIMUM COUGH 20 mg/10mL?
The NDC (National Drug Code) for BRONCOCHEM MAXIMUM COUGH 20 mg/10mL is 65131-100, listed by LABORATORIO MAGNACHEM INTERNATIONAL SRL.
Other BRONCOCHEM MAXIMUM COUGH Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)